The CREB1‐CENPE axis represents a promising target for therapeutic intervention in ccRCC, and further exploration of this pathway may lead to the development of new treatment strategies for this challenging malignancy. The gene discussed is CREB1; the disease is nonpapillary renal cell carcinoma.